Inhibitor Therapeutics INTI
OTC INTI
$0.08 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Inhibitor Therapeutics (INTI) Net Long-Term Debt Issued (Repaid) (2013 - 2023)

Updated

Inhibitor Therapeutics' Non-Current Debt was $273,638 in FY2014, down 25.3% from $366,130 in FY2013.

Analysis

Inhibitor Therapeutics (INTI) Net Long-Term Debt Issued (Repaid) (2013 - 2023) Analysis & Trends

  • Per Business Quant data, Non-Current Debt in earlier years was $366,130 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Inhibitor Therapeutics 13.90 Mn 6.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -411,000.00
Sep 30, 2022 80,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 50,000.00
Jun 30, 2021 75,000.00
Mar 31, 2021 101,000.00
Dec 31, 2020 55,000.00
Jun 30, 2020 41,600.00
Jun 30, 2014 164,894.00
Mar 31, 2014 108,744.00
Dec 31, 2013 169,542.00
Sep 30, 2013 127,324.00
API Access

Inhibitor Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INTI&period=max&api_key=YOUR_API_KEY